Press release
Benign Prostatic Hyperplasia Therapeutics Market to Undertake Strapping Growth During 2019
Benign prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological disorder that involves proliferation of the cellular components of the prostrate. BPH is the most common form of neoplasm in men. BPH results in the formation of large nodes and nodules in the periurethral region of the prostate. The significantly large nodules compresses the urethral canal that causes to partial or complete urinary tract obstruction which inhibits the normal flow of urine. Obstruction in the urinary tract further leads to complications such as urinary retention, urinary tract infections and urinary hesitancy.Read Report Overview @ https://www.transparencymarketresearch.com/bph-therapeutics-market.html
Geographically, North America is the leading market due to high prevalence rate of benign prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies reports that 90% of men in the U.S., aged between 45 and 80 years suffer from some type of LUTS and approximately 14 million men in the U.S. have symptoms of BPH. Asia-Pacific is also expected to witness a significant growth due to the rise in various urological disorders and complications. However, BPH tends to be more progressive in African-American men owing to the presence of high testosterone level in their body.
Rise in geriatric population is expected to be one of the major driver that might drive the market. Additionally, increased awareness for prostate cancer and other urological disorders, are also expected to fuel the growth of the global BPH therapeutics market.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1872
However, high adoption rate of minimally invasive surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic prostatectomy and transurethral needle ablation (TUNA) might impede the growth of the BPH therapeutics market.
Some of the key players in the benign prostatic hyperplasia (BPH) therapeutics Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company, EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1872
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Benign Prostatic Hyperplasia Therapeutics Market to Undertake Strapping Growth During 2019 here
News-ID: 1195791 • Views: β¦
More Releases from Transparency Market Research
Hand Dryer Market Size Forecast to USD 4.83 Billion by 2036 with Growing Focus o β¦
Hand Dryer Market Outlook 2036
The global hand dryer market was valued at US$ 2.23 Billion in 2025 and is projected to reach US$ 4.83 Billion by 2036, expanding at a steady CAGR of 7.2% from 2026 to 2036. Market growth is driven by increasing emphasis on hygiene and sanitation, rising adoption in commercial infrastructure, and growing preference for eco-friendly and cost-effective hand drying solutions.
π Get sample market research report copyβ¦
Smart Glass Market Outlook 2036: Projected to Reach USD 35.8 Billion at 14.5% CA β¦
The global smart glass market was valued at US$ 8.1 Bn in 2025 and is projected to surge to US$ 35.8 Bn by 2036, expanding at a robust CAGR of 14.5% from 2026 to 2036. This nearly 4.4x growth over eleven years underscores the accelerating demand for intelligent glazing solutions across commercial, residential, automotive, and infrastructure sectors.
North America emerged as the leading regional market in 2025, accounting for 29.8% ofβ¦
Smoking Cessation and Nicotine De-Addiction Market to Reach USD 46.4 Bn by 2036, β¦
The global smoking cessation and nicotine de-addiction market is witnessing strong and sustained growth, fueled by intensifying public health initiatives and rising awareness about the long-term consequences of tobacco use. Valued at USD 15.5 Bn in 2025, the market is projected to expand at a robust CAGR of 10.5% from 2026 to 2036, reaching USD 46.4 Bn by 2036.
Smoking cessation solutions encompass a wide range of products and services designedβ¦
3D Imaging Market to be Worth USD 266 Bn by 2036 - By Component Type / By End-Us β¦
The global 3D imaging market is witnessing exponential growth, reflecting strong demand across healthcare, manufacturing, media, and industrial sectors. Valued at US$ 50 billion in 2025, the market is projected to reach US$ 266 billion by 2036, expanding at a robust CAGR of 18.2% from 2026 to 2036.
Get a concise overview of key insights from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2743
This impressive trajectory highlights the rapid integration of advanced imagingβ¦
More Releases for BPH
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M β¦
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.β¦
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030
The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion inβ¦
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M β¦
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.β¦
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
πππ, πππ° πππ«π¬ππ²- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging maleβ¦
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031).
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the marketβ¦
Laser BPH Devices Market Expected to Reach $765.4 Million by 2031
Laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous expansion of the prostate gland. Frequent urination, difficulty starting to urinate, a weak stream, the inability to urinate, or a loss of bladder control are examples of symptoms.β¦
